Colorectal cancer study for newly diagnosed patients
Part of Cancer, Digestive system clinical trials.
This study enrolls people newly diagnosed with colon or rectal cancer to learn about their care and outcomes. You might be able to join if you meet the age, language, and consent requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18–89 years old (or 18–69 if you enroll after 09/01/2021, depending on the specific part of the study)
- Have a new diagnosis of colon or rectal cancer (any stage I through IV)
- Be able to speak and read English or German, as required by the study site
- Be able to understand the study and give consent, and be physically/mentally able to participate
- Plan to enroll through one of the participating study locations
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information from people with newly diagnosed colon or rectal cancer, to better understand the disease and support future research. It may help you and others by improving how colorectal cancer is studied and potentially treated over time.
This study follows people age 40 and older to see how well colorectal cancer screening works in everyday community care. You may answer risk and follow-up questions over time, and the study looks for any cancer diagnoses that happen outside the study hospitals.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This study looks at patterns of colorectal (colon and rectum) findings in people who are having a colonoscopy as part of routine care. It may help improve how doctors detect and understand colorectal cancer and related growths over time.
This study tests whether education plus a stool-based screening kit can increase colorectal cancer screening rates in primary care settings. If you join, you may receive educational materials and a stool test to help detect colon cancer early.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.